Kristina Burow
InvestorFounder and Managing Partner at Pachamama Ventures · Managing Director at ARCH Venture Partners · Board director at Mirador Therapeutics · Board director at Metsera · Board director at Treeline Biosciences
United States
Writes $50K – $150M checks · typically $50K
Find your path to Kristina
119 people in our graph share verified history with Kristina — schools, employers, funds. One of them is your warm intro.
About
Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- k•••@archventure.comreveal100% confident
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Board director at Mirador Therapeutics
Intro paths
In turn, Kristina can intro founders to Mirador Therapeutics's investors below.
Mirador Therapeutics's investors · 3
Co-founders at Mirador Therapeutics
Board director at Metsera
Intro paths
In turn, Kristina can intro founders to Metsera's investors below.
Metsera's investors · 7
Co-founders at Metsera
Board director at Treeline Biosciences
Intro paths
In turn, Kristina can intro founders to Treeline Biosciences's investors below.
Treeline Biosciences's investors · 8
Co-founders at Treeline Biosciences
Deals · 13
Autobahn Therapeutics, Inc.Board seat
via ARCH Venture Partners · filed Aug 2024 · $120M raise
Boundless BioBoard seat
via ARCH Venture Partners · filed May 2021 · $105.6M raise
Vividion TherapeuticsBoard seat
via ARCH Venture Partners · filed May 2019 · $82M raise
Beam TherapeuticsBoard seat
via ARCH Venture Partners · filed Mar 2019 · $83.6M raise
Scholar Rock Holding Corp, Inc.Board seat
via ARCH Venture Partners · filed Jan 2018 · $47M raise
Sienna BiopharmaceuticalsBoard seat
via ARCH Venture Partners · filed May 2017 · $40.5M raise
TrelysBoard seat
via ARCH Venture Partners · filed Apr 2017 · $80K raise
BoragenBoard seat
via ARCH Venture Partners · filed Mar 2017 · $10.5M raise
MetacrineBoard seat
via ARCH Venture Partners · filed Nov 2016 · $37.8M raise
Scholar RockBoard seat
via ARCH Venture Partners · filed Jan 2016 · $40M raise
AgbiomeBoard seat
via ARCH Venture Partners · filed Aug 2015 · $34.5M raise
LyceraBoard seat
via ARCH Venture Partners · filed Jun 2015
ErascaQuoted
via ARCH Venture Partners · filed Apr 2020
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Sources: SEC Form D filings · curated public sources.
Colleagues at Pachamama Ventures
Frequently asked questions
- Who is Kristina Burow?
- Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.
- Where does Kristina Burow work?
- Kristina Burow is Founder and Managing Partner at Pachamama Ventures and Board director at Mirador Therapeutics and Board director at Metsera and Board director at Treeline Biosciences.
- What does Kristina Burow invest in?
- Kristina Burow invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Kristina Burow write?
- Kristina Burow typically writes checks of $50K – $150M.
- What boards does Kristina Burow sit on?
- Kristina Burow holds tracked board seats at Agbiome, Autobahn Therapeutics, Inc., Beam Therapeutics, Boragen, Boundless Bio, Gossamer Bio, Lycera, Metacrine, Metsera, Mirador Therapeutics.
- What companies has Kristina Burow invested in?
- Investments tracked here include Autobahn Therapeutics, Inc., Dewpoint Therapeutics, Erasca, Gossamer Bio, Kilimanjaro Energy, Lycera, Magnet Biomedicine, Metsera, Mirador Therapeutics, Neumora Therapeutics, Orbital Therapeutics, Pretzel Therapeutics, and 6 more.